2003D-0206 - Draft Guidance for Industry on Exocrine Pancreatic Insufficiency Drug Products--Submitting New Drug Application; Availability

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC16
  



  

  

  



  

  
Submitter : 
  

  
Ms. Subha Indrarajah
  

  
Date & Time: 
  

  
07/12/2004 12:07:34
  



  

  
Organization : 
  

  
CanReg Inc. on behalf of Axcan Scandipharm Inc.
  



  

  
Drug Industry
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 RE: Docket No. 2003D-0206, CDER 200275 (Draft) Guidance for Industry    Exocrine Pancreatic Insufficiency Drug Products ? Submitting NDAs, Federal Register, Vol. 69, April 28, 2004 [FR Doc. 04-09653]